These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30745677)

  • 1. Antipsychotic augmentation in the treatment of obsessive-compulsive disorder.
    Thamby A; Jaisoorya TS
    Indian J Psychiatry; 2019 Jan; 61(Suppl 1):S51-S57. PubMed ID: 30745677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of the use of risperidone, paliperidone and aripiprazole as augmenting agents for obsessive-compulsive disorder.
    Brakoulias V; Stockings E
    Expert Opin Pharmacother; 2019 Jan; 20(1):47-53. PubMed ID: 30360669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A benzisothiazole derivative and antipsychotic agent, perospirone, for augmentation of selective serotonin reuptake inhibitors (SSRIs) in refractory obsessive-compulsive disorder (OCD): two patient case series.
    Matsunaga H; Matsui T; Ohya K; Okino K; Hayashida K; Maebayashi K; Kiriike N; Stein DJ
    Int J Psychiatry Clin Pract; 2006; 10(2):142-5. PubMed ID: 24940965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation strategies in obsessive-compulsive disorder.
    Arumugham SS; Reddy JY
    Expert Rev Neurother; 2013 Feb; 13(2):187-202; quiz 203. PubMed ID: 23368806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic treatment in obsessive-compulsive disorder: a literature review.
    Keuneman RJ; Pokos V; Weerasundera R; Castle DJ
    Aust N Z J Psychiatry; 2005 May; 39(5):336-43. PubMed ID: 15860020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine augmentation of serotonin reuptake inhibitors in severe and long-term treatment-resistant obsessive-compulsive disorder.
    Arrojo-Romero M; Tajes Alonso M; de Leon J
    Case Rep Psychiatry; 2013; 2013():612459. PubMed ID: 23936714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obsessive-compulsive disorder comorbid with schizophrenia and bipolar disorder.
    Sharma LP; Reddy YCJ
    Indian J Psychiatry; 2019 Jan; 61(Suppl 1):S140-S148. PubMed ID: 30745688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-generation antipsychotics for obsessive compulsive disorder.
    Komossa K; Depping AM; Meyer M; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008141. PubMed ID: 21154394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature.
    Wright BM; Eiland EH; Lorenz R
    Pharmacotherapy; 2013 Mar; 33(3):344-59. PubMed ID: 23456734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of treatments for patients with obsessive-compulsive disorder: a systematic review.
    Choi YJ
    J Am Acad Nurse Pract; 2009 Apr; 21(4):207-13. PubMed ID: 19366379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.
    Maher AR; Maglione M; Bagley S; Suttorp M; Hu JH; Ewing B; Wang Z; Timmer M; Sultzer D; Shekelle PG
    JAMA; 2011 Sep; 306(12):1359-69. PubMed ID: 21954480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is it time for revision of the section on obsessive-compulsive disorder in the Guideline on Anxiety Disorders?].
    van Ingen Schenau WJ; Wisman PW
    Tijdschr Psychiatr; 2007; 49(5):315-25. PubMed ID: 17492582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ziprasidone Augmentation in an Adolescent with Obsessive Compulsive Disorder: A Case Report.
    Demirkaya SK; Alyanak B
    Psychopharmacol Bull; 2016 Mar; 46(1):73-76. PubMed ID: 27738375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B; Bonnet-Perrin E
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole-induced obsessive-compulsive symptoms.
    Nafisa D; Kakunje A
    Ind Psychiatry J; 2022; 31(1):158-161. PubMed ID: 35800864
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.